title: Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
abstract: An on-line microdialysis approach was developed to estimate changes in tyrosine hydroxylase activity in the locus ceruleus noradrenergic neurons of anesthetized rats by measuring the 3,4-dihydroxyphenylalanine (DOPA) accumulation in the extracellular fluid during perfusion of an aromatic amino acid decarboxylase inhibitor through a dialysis probe. The aromatic amino acid decarboxylase inhibitor used was difluoromethyl-DOPA, which was shown to be more stable than NSD 1015 or Ro 4-4602 in the perfusion fluid. A 1-h perfusion of a 10(-4) mol/L of difluoromethyl-DOPA solution induced a linear increase in DOPA concentration in the locus ceruleus dialysates that achieved a steady state within 1 h. The identity of DOPA accumulated in dialysates during aromatic amino acid decarboxylase inhibition was confirmed by the disappearance of the chromatographic peak when DOPA formation was blocked by the administration of alpha-methyl-p-tyrosine. Systemic administration of the alpha 2-antagonist piperoxane before difluoromethyl-DOPA perfusion markedly increased the DOPA concentration during both the accumulation and the steady-state periods, showing that the present technique is a suitable in vivo approach to monitor changes in tyrosine hydroxylase activity occurring in the locus ceruleus neurons.
authors.affiliation: Université Claude Bernard et CNRS UMR 105, Laboratoire de Neuropharmacologie, Faculté de Pharmacie, Lyon, France.
authors.forename: F
authors.initials: F
authors.lastname: Robert
authors.forename: L
authors.initials: L
authors.lastname: Lambás-Señas
authors.forename: C
authors.initials: C
authors.lastname: Ortemann
authors.forename: J F
authors.initials: JF
authors.lastname: Pujol
authors.forename: B
authors.initials: B
authors.lastname: Renaud
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D003956:Dialysis / Q000379:methods; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology*; D007700:Kinetics; D008125:Locus Coeruleus / Q000201:enzymology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D008832:Microchemistry; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*; D019805:alpha-Methyltyrosine
chemical_list: D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D008781:Methyltyrosines; D015102:3,4-Dihydroxyphenylacetic Acid; C028477:alpha-difluoromethyl-DOPA; D004295:Dihydroxyphenylalanine; D019805:alpha-Methyltyrosine; D001545:Benserazide; C004297:3-hydroxybenzylhydrazine; D014446:Tyrosine 3-Monooxygenase